NCT00528515

Brief Summary

The purpose of this study is to prove if anesthesia maintained with the inhaled volatile anesthetic desflurane is superior to the intravenously applied propofol anesthesia in off-pump coronary artery bypass grafting (OP-CABG) surgery as measured by following parameters:

  1. 1.hemodynamic parameters during and after the operation,
  2. 2.pulmonary gas exchange, need for mechanical ventilation and for ICU and intrahospital stay,
  3. 3.release of heart muscle injury markers in response to surgery and intraoperative ischaemia,
  4. 4.inflammatory response to the operation.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
80

participants targeted

Target at P25-P50 for phase_4 coronary-artery-disease

Timeline
Completed

Started Feb 2007

Shorter than P25 for phase_4 coronary-artery-disease

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 1, 2007

Completed
7 months until next milestone

First Submitted

Initial submission to the registry

September 11, 2007

Completed
1 day until next milestone

First Posted

Study publicly available on registry

September 12, 2007

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2008

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2008

Completed
Last Updated

May 16, 2008

Status Verified

May 1, 2008

Enrollment Period

1.1 years

First QC Date

September 11, 2007

Last Update Submit

May 15, 2008

Conditions

Keywords

anesthesia intravenouspropofolanesthesia inhalationdesfluraneheart surgerycoronary artery by-pass off-pumphemodynamic processesanesthesia

Outcome Measures

Primary Outcomes (1)

  • Markers of heart muscle injury and inflammation will be compared: troponin I, creatinine phosphokinase and its heart specific fraction, C-reactive protein.

    within the first 2. days after surgery.

Secondary Outcomes (1)

  • Evidence of clinically definite heart infarct confirmed by ECG and/or echocardiography, and heart muscle specific creatinine phosphokinase increase.

    To discharge from hospital (usually within 7 days)

Study Arms (2)

1

ACTIVE COMPARATOR

propofol

Drug: Diprivan (propofol), Astra-Zeneca

2

EXPERIMENTAL

desflurane

Drug: Suprane (desflurane), Baxter

Interventions

continuous intravenous infusion with a dose of 3-5 mg/kg/h

Also known as: propofol
1

a vapor concentration of 3-7 vol% is maintained with use of vaporizer and under control of arterial blood pressure, heart rate, and BIS index.

Also known as: desflurane
2

Eligibility Criteria

Age18 Years - 75 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients with coronary artery disease qualified for CABG off-pump surgery
  • Elective surgery
  • Signed informed consent

You may not qualify if:

  • Left ventricle ejection fraction \< 30%
  • Serum creatinine \> 2 mg/dL
  • Emergency surgery
  • Denied consent

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Department of Cadiac Anesthesiology, Medical University of Gdańsk

Gdansk, 80-211, Poland

Location

Related Publications (5)

  • Xia Z, Luo T. Sevoflurane or desflurane anesthesia plus postoperative propofol sedation attenuates myocardial injury after coronary surgery in elderly high-risk patients. Anesthesiology. 2004 Apr;100(4):1038-9; author reply 1039-40. doi: 10.1097/00000542-200404000-00050. No abstract available.

    PMID: 15087655BACKGROUND
  • Tritapepe L, Landoni G, Guarracino F, Pompei F, Crivellari M, Maselli D, De Luca M, Fochi O, D'Avolio S, Bignami E, Calabro MG, Zangrillo A. Cardiac protection by volatile anaesthetics: a multicentre randomized controlled study in patients undergoing coronary artery bypass grafting with cardiopulmonary bypass. Eur J Anaesthesiol. 2007 Apr;24(4):323-31. doi: 10.1017/S0265021506001931. Epub 2006 Dec 8.

    PMID: 17156509BACKGROUND
  • Guarracino F, Landoni G, Tritapepe L, Pompei F, Leoni A, Aletti G, Scandroglio AM, Maselli D, De Luca M, Marchetti C, Crescenzi G, Zangrillo A. Myocardial damage prevented by volatile anesthetics: a multicenter randomized controlled study. J Cardiothorac Vasc Anesth. 2006 Aug;20(4):477-83. doi: 10.1053/j.jvca.2006.05.012.

    PMID: 16884976BACKGROUND
  • De Hert SG, Cromheecke S, ten Broecke PW, Mertens E, De Blier IG, Stockman BA, Rodrigus IE, Van der Linden PJ. Effects of propofol, desflurane, and sevoflurane on recovery of myocardial function after coronary surgery in elderly high-risk patients. Anesthesiology. 2003 Aug;99(2):314-23. doi: 10.1097/00000542-200308000-00013.

    PMID: 12883404BACKGROUND
  • Mrozinski P, Lango R, Biedrzycka A, Kowalik MM, Pawlaczyk R, Rogowski J. Comparison of haemodynamics and myocardial injury markers under desflurane vs. propofol anaesthesia for off-pump coronary surgery. A prospective randomised trial. Anaesthesiol Intensive Ther. 2014 Jan-Mar;46(1):4-13. doi: 10.5603/AIT.2014.0002.

Related Links

MeSH Terms

Conditions

Coronary Artery Disease

Interventions

PropofolDesflurane

Condition Hierarchy (Ancestors)

Coronary DiseaseMyocardial IschemiaHeart DiseasesCardiovascular DiseasesArteriosclerosisArterial Occlusive DiseasesVascular Diseases

Intervention Hierarchy (Ancestors)

PhenolsBenzene DerivativesHydrocarbons, AromaticHydrocarbons, CyclicHydrocarbonsOrganic ChemicalsEthyl EthersEthersMethyl EthersHydrocarbons, FluorinatedHydrocarbons, Halogenated

Study Officials

  • Romuald Lango, M.D., Ph.D.

    Medical University of Gdańsk, Department of Cardiac Anesthesiology

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
phase 4
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER

Study Record Dates

First Submitted

September 11, 2007

First Posted

September 12, 2007

Study Start

February 1, 2007

Primary Completion

March 1, 2008

Study Completion

March 1, 2008

Last Updated

May 16, 2008

Record last verified: 2008-05

Locations